Use of dupilumab on the treatment of moderate-to-severe asthma: a systematic review.

Cintia Bassani Larissa Rossi Kaian Siveris Rafaella Lorenzon Sferelli Leonardo Saraiva Luciana Kase Tanno

Published in: Revista da Associacao Medica Brasileira (1992) (2019)

Dupilumab is promising for the treatment of asthma, whereas conventional therapy is deemed to be insufficient. More additional studies are needed to confirm the long-term safety and effectiveness.

Keyphrases

randomized controlled trial
systematic review
chronic obstructive pulmonary disease
stem cells
lung function
replacement therapy
mesenchymal stem cells
cystic fibrosis
air pollution